Molecular basis of subtotal complement C6 deficiency. A carboxy-terminally truncated but functionally active C6. 1995

R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
Molecular Immunopathology Unit, Medical Research Council Centre, Cambridge, United Kingdom.

Individuals with subtotal complement C6 deficiency possess a C6 molecule that is 14% shorter than normal C6 and present in low but detectable concentrations (1-2% of the normal mean). We now show that this dysmorphic C6 is bactericidally active and lacks an epitope that was mapped to the most carboxy-terminal part of C6 using C6 cDNA fragments expressed as fusion proteins in the pUEX expression system. We thus predicted that the abnormal C6 molecule might be carboxy-terminally truncated and sought a mutation in an area approximately 14% from the carboxy-terminal end of the coding sequence. By sequencing PCR-amplified products from this region, we found, in three individuals from two families, a mutation that might plausibly be responsible for the defect. All three have an abnormal 5' splice donor site of intron 15, which would probably prevent splicing. An in-frame stop codon is found 17 codons downstream from the intron boundary, which would lead to a truncated polypeptide 13.5% smaller than normal C6. This result was unexpected, as earlier studies mapped the C5b binding site, or a putative enzymatic region, to this part of C6. Interestingly, all three subjects were probably heterozygous for both subtotal C6 and complete C6 deficiency.

UI MeSH Term Description Entries
D007154 Immune System Diseases Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both. Immune Disorders,Immune System Disorders,Immunologic Diseases,Diseases of Immune System,Immune Diseases,Immunological Diseases,Disease, Immune,Disease, Immune System,Disease, Immunologic,Disease, Immunological,Disorder, Immune System,Immune Disease,Immune Disorder,Immune System Disease,Immune System Disorder,Immunologic Disease,Immunological Disease
D008297 Male Males
D008589 Meningococcal Infections Infections with bacteria of the species NEISSERIA MENINGITIDIS. Meningococcal Septicemia,Infections, Meningococcal,Meningococcal Disease,Infection, Meningococcal,Meningococcal Diseases,Meningococcal Infection,Septicemia, Meningococcal
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D001770 Blood Bactericidal Activity The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST. Activities, Blood Bactericidal,Activity, Blood Bactericidal,Bactericidal Activities, Blood,Bactericidal Activity, Blood,Blood Bactericidal Activities
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003183 Complement C6 A 105-kDa serum glycoprotein with significant homology to the other late complement components, C7-C9. It is a polypeptide chain cross-linked by 32 disulfide bonds. C6 is the next complement component to bind to the membrane-bound COMPLEMENT C5B in the assembly of MEMBRANE ATTACK COMPLEX. It is encoded by gene C6. C6 Complement,Complement 6,Complement Component 6,C6, Complement,Complement, C6,Component 6, Complement
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
January 1992, Immunology,
R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
March 2003, Immunology,
R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
January 2004, Immunobiology,
R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
December 1998, Nature genetics,
R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
March 1991, Clinical and experimental immunology,
R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
May 1985, Laboratory investigation; a journal of technical methods and pathology,
R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
February 1999, Journal of immunology (Baltimore, Md. : 1950),
R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
August 2003, Clinical and experimental immunology,
R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
August 1983, Journal of the South Carolina Medical Association (1975),
R Würzner, and M J Hobart, and B A Fernie, and D Mewar, and P C Potter, and A Orren, and P J Lachmann
February 1996, The Journal of clinical investigation,
Copied contents to your clipboard!